References
- Japan Rheumatism Friendship Association. Rheumatism white paper, 1990 (in Japanese).
- Japan Rheumatism Friendship Association. Rheumatism white paper, 2000 (in Japanese).
- Uchida S. Actarit (in Japanese). Prog Med 1995;15:1646–51.
- Urano F, Suzuki S. Treatment of actarit for the old onset patients with rheumatoid arthritis (in Japanese). J Chubu Rheum Assoc 1998;29:34–5.
- Mizutani S. Clinical and radiographic study of actarit in rheuma-toid arthritis, especially early RA and older onset RA (in Japanese). Ftheumatology 1998;20:197–204.
- Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JT, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
- Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Ftheumatology rheuma-toid arthritis preliminary core set of disease activity measures for clinical trials. Arthritis Rheum 1993;36:729–40.
- Nakajima H. Clinical and radiological study of elderly onset rheu-matoid arthritis (in Japanese). Okayama Igakkai Zasshi 1989;101: 901–10.
- Matsubara T. The basic and clinical use of DMARDs (in Japanese). Ftheumatology 1999;22:81–97.
- Shiokawa Y, Shichikawa K, Nobunaga M, Sugawara S, Abe T, Hirose S, et al. Clinical study of a new anti-rheumatic drug, MS-932, on rheumatoid arthritis. Double-blind comparative study with a placebo (in Japanese). Ftinshoiyaku 1991;7 Suppl 2:113–47.
- Okano Y, Akizuki M, Kondo H, Kawai S, Suzuki Y, Takeuchi T, et al. A new approach to assessing rheumatoid arthritis(RA) dis-ease activity using the American College of Ftheumatology core set of disease activity measures for RA trials. A multicenter study (in Japanese). Ryumachi 1997;37:467–75.
- Nobunaga M. Long term administration study of a new DMARD, actarit, on rheumatoid arthritis (in Japanese). Ftinshoiyaku 1994;10:947–62.
- Ishida H, Yanagida H. The adjunctive therapy with actarit and other DMARDs for severe patients with rheumatoid arthritis (in Japanese). Ftheumatology 1999;21:204–12.
- Kitani A. Inhibitory effect of actarit on the adhesion between VCAM-1 and VLA-4 (in Japanese). J Chubu Rheum Assoc 1998;29:26–7.
- Matsubara T. The roles of small blood vessels in rheumatoid syno-vitis and the DMARD - induced inhibition of VEGF production and its receptor expression by EC (in Japanese). Igakunoayumi 1998;186:129–32.
- Fujisawa H, Nishimura T, Inoue Y, Ogaya S, Shibata Y, Nakagawa Y, et al. Antiinflammatory properties of the new antirheumatic agent 4-acetylaminophenylacetic acid. Arzneimittel-Forsch./Drug Res 1990;40:693–7.
- Totokawa S, Furuya T, Nakajima A, Suzuki T, Kashiwazaki S. Effect of low-dose methotrexate therapy in rheumatoid arthritis. A comparison of three different dosage regimens (in Japanese). Ryumachi 1997;37:681–7.
- Izumihara T, Matsuda T, Nagai S, Yoshitama T, et al. The adjunc-tive therapy with actarit for patients with rheumatoid arthritis who are not well controlled during mono-DMARD therapy (in Japanese). Prog Med 2001;21:1749–55.
- Matsubara S, Tsukano M. Multi clinical study of Actarit on rheumatoid arthritis (in Japanese). Ryumachi 2001;41:435.
- Schmidt KL, Frend V. Onset of rheumatoid arthritis in the elderly. Dtsch Med Wochenschr 1982;107:1506–10.
- Schmidt KL. Entzundliche rheumaerkrankungen im alter. Z Ftheumatol 1982;41:37–46.
- Terkeltaub R, Esdaile J, Decary J, Tannenbaum H. A clinical study of older age rheumatoid arthritis with comparison to a younger group. J Rheumatol 1983;10:418–24.